New cancer clinical trial: A Randomized Phase III Study Comparing POF (Paclitaxel/Oxaliplatin/Leucovorin/5-FU) With S-1 Plus Docetaxel as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer

Published on: December 27, 2018 at 12:00PM
Condition:   Gastric Cancer Stage III
Interventions:   Drug: POF;   Drug: Docetaxel/S-1
Sponsor:   Fujian Cancer Hospital
Not yet recruiting
http://bit.ly/2QTwyiv